| scholarly article | Q13442814 |
| P50 | author | Peter Garred | Q59433407 |
| Stefano Fumagalli | Q59673185 | ||
| Carlo Perego | Q93176534 | ||
| P2093 | author name string | Stefano Fumagalli | |
| Maria-Grazia De Simoni | |||
| Anne Rosbjerg | |||
| Mikkel-Ole Skjoedt | |||
| Ninette Genster | |||
| Katrine Pilely | |||
| Angela M R Ferrante | |||
| Angela M. R. Ferrante | |||
| P2860 | cites work | Regulation of complement activation by C-reactive protein | Q22010264 |
| Interleukin-1-inducible genes in endothelial cells. Cloning of a new gene related to C-reactive protein and serum amyloid P component | Q24294475 | ||
| C-reactive protein collaborates with plasma lectins to boost immune response against bacteria | Q24312726 | ||
| C-reactive protein: a critical update | Q24672855 | ||
| Expression of a long pentraxin, PTX3, by monocytes exposed to the mycobacterial cell wall component lipoarabinomannan | Q24675983 | ||
| The physiological structure of human C-reactive protein and its complex with phosphocholine | Q27618638 | ||
| Structure of pentameric human serum amyloid P component | Q27731194 | ||
| Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition | Q28115835 | ||
| The angiogenic inhibitor long pentraxin PTX3 forms an asymmetric octamer with two binding sites for FGF2 | Q28118397 | ||
| M-ficolin interacts with the long pentraxin PTX3: a novel case of cross-talk between soluble pattern-recognition molecules | Q28118843 | ||
| Binding of the long pentraxin PTX3 to factor H: interacting domains and function in the regulation of complement activation | Q29147380 | ||
| Complement: a key system for immune surveillance and homeostasis | Q29615484 | ||
| NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals | Q29615704 | ||
| C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women | Q29616306 | ||
| Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 | ||
| Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation | Q33644572 | ||
| Associations of pentraxin 3 with cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis | Q33748025 | ||
| Isolation and characterization of pharmaceutical grade human pentraxins, serum amyloid P component and C-reactive protein, for clinical use. | Q33796862 | ||
| Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11. | Q33874500 | ||
| PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans | Q33912738 | ||
| Human pentraxin 3 binds to the complement regulator c4b-binding protein. | Q34018825 | ||
| An integrated view of humoral innate immunity: pentraxins as a paradigm | Q34020449 | ||
| Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction | Q34056876 | ||
| Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group | Q34064191 | ||
| Production of the long pentraxin PTX3 in advanced atherosclerotic plaques | Q34128059 | ||
| Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study | Q34150807 | ||
| Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. | Q34184675 | ||
| Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes. | Q34324823 | ||
| C-reactive Protein | Q34344434 | ||
| Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction | Q34357988 | ||
| Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. | Q34450228 | ||
| Pentraxin-3 serum levels are associated with disease severity and mortality in patients with systemic inflammatory response syndrome | Q34988829 | ||
| C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis | Q35182277 | ||
| Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure | Q35501399 | ||
| Compstatin analog Cp40 inhibits complement dysregulation in vitro in C3 glomerulopathy | Q35877192 | ||
| Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study | Q37141153 | ||
| Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release | Q37700323 | ||
| Lectin Pathway of Complement Activation Is Associated with Vulnerability of Atherosclerotic Plaques | Q37703122 | ||
| Pentraxins in the activation and regulation of innate immunity | Q38991073 | ||
| Regulation of complement activation by C-reactive protein: targeting of the inhibitory activity of C4b-binding protein | Q40271737 | ||
| Complement activation by cholesterol crystals triggers a subsequent cytokine response | Q40520440 | ||
| C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction | Q40857092 | ||
| Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease | Q40868032 | ||
| Three-dimensional confocal analysis of microglia/macrophage markers of polarization in experimental brain injury | Q41976314 | ||
| Heterocomplexes of mannose-binding lectin and the pentraxins PTX3 or serum amyloid P component trigger cross-activation of the complement system | Q42584975 | ||
| Production of the soluble pattern recognition receptor PTX3 by myeloid, but not plasmacytoid, dendritic cells | Q44600227 | ||
| Mechanisms of complement activation by crystalline cholesterol | Q45723549 | ||
| TNFalpha-induced long pentraxin PTX3 expression in human lung epithelial cells via JNK. | Q46844038 | ||
| Comparative levels of high molecular weight (19S) gamma globulin in maternal and umbilical cord sera. | Q47434713 | ||
| Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials | Q48458509 | ||
| Molecular organization of human Ficolin-2. | Q51808805 | ||
| Studies on the interactions between C-reactive protein and complement proteins. | Q52576446 | ||
| Intraobserver and interobserver variability and spatial differences in histologic examination of carotid endarterectomy specimens. | Q53029141 | ||
| Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. | Q53510759 | ||
| Serum amyloid P and cardiovascular disease in older men and women: results from the Cardiovascular Health Study. | Q53583734 | ||
| The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina | Q58230388 | ||
| Cholesterol Crystals Activate the Lectin Complement Pathway via Ficolin-2 and Mannose-Binding Lectin: Implications for the Progression of Atherosclerosis | Q63727982 | ||
| Independent association of serum amyloid P component, protein S, and complement C4b with complement C4b-binding protein and subsequent association of the complex with membranes | Q68434491 | ||
| Generation of complement anaphylatoxins and C5b-9 by crystalline cholesterol oxidation derivatives depends on hydroxyl group number and position | Q68543870 | ||
| Elevation of C-reactive protein in "active" coronary artery disease | Q68696120 | ||
| Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q | Q70120011 | ||
| Evidence for the binding of human serum amyloid P component to Clq and Fab gamma | Q70317183 | ||
| Cholesterol and atheroma lipids activate complement and stimulate granulocytes. A possible mechanism for amplification of ischemic injury in atherosclerotic states | Q72899156 | ||
| Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation | Q73083027 | ||
| C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries | Q77318966 | ||
| Serum amyloid P colocalizes with apolipoproteins in human atheroma: functional implications | Q80609723 | ||
| Evidence that complement protein C1q interacts with C-reactive protein through its globular head region | Q82625735 | ||
| Pentraxin 3 is a new inflammatory marker correlated with left ventricular diastolic dysfunction and heart failure with normal ejection fraction | Q83395035 | ||
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 1040 | |
| P577 | publication date | 2017-08-29 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | C-Reactive Protein Binds to Cholesterol Crystals and Co-Localizes with the Terminal Complement Complex in Human Atherosclerotic Plaques | |
| P478 | volume | 8 |
| Q91868632 | Binding of von Willebrand Factor to Complement C1q Decreases the Phagocytosis of Cholesterol Crystals and Subsequent IL-1 Secretion in Macrophages |
| Q91893013 | C-reactive protein (CRP) recognizes uric acid crystals and recruits proteases C1 and MASP1 |
| Q92405017 | Functionality of C-Reactive Protein for Atheroprotection |
| Q61447776 | The phagocytic state of brain myeloid cells after ischemia revealed by superresolution structured illumination microscopy |
| Q92740632 | Zebrafish C-reactive protein isoforms inhibit SVCV replication by blocking autophagy through interactions with cell membrane cholesterol |
Search more.